IP Library › Granted Patent US 9,005,965
Granted Patent B2
US 9,005,965 · App. 13/005,978 · Granted Apr 14, 2015

Stem cells culture systems

Inventors: Etti Ben Shushan (Jerusalem, IL); Shelly Tannenbaum (Efrat, IL); Pavel Itsykson (Ramat Gan, IL); Eyal Banin (Jerusalem, IL); Benjamin Reubinoff (Doar Na Haela, IL)
Assignee: Hadasit Medical Research Services & Development Limited
C12N5/0606C12N5/0621C12N2500/32C12N2500/38C12N2500/44C12N2500/99C12N2501/115C12N2501/155C12N2501/16C12N2506/02C12N2533/52C12N2502/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,005,965
App. No.
13/005,978
Granted
Apr 14, 2015
Kind
B2
Abstract

Provided are systems and methods for providing human cell cultures. Further provided are cultures of feeder cells for use in stem cell technology, as well as cultures, culture systems and methods for maintenance and propagating of stem cells in an undifferentiated state as well as for the development of somatic cells cultures from stem cells, the somatic cell cultures being free of extraembryonic cells.

Claims (16)

1. A method for maintaining human pluripotent stem cells in an undifferentiated state, comprising:

providing human umbilical cord fibroblast feeder cells isolated and expanded from human umbilical cord;

incubating the human pluripotent stem cells in a culture system comprising the human umbilical fibroblast feeder cells, the feeder cells consisting essentially of human umbilical cord fibroblast feeder cells, the culture system being free from antibacterial agents and mercaptoethanol; and

maintaining the human pluripotent stem cells in an undifferentiated state for at least 10 weeks.

2. The method of claim 1 , wherein the human pluripotent stem cells are embryonic stem cells.

3. The method of claim 1 , for propagating the human pluripotent stem cells in an undifferentiated state.

4. The method of claim 1 , wherein the human umbilical cord feeder cells consist of 100% human umbilical cord fibroblast feeder cells.

5. The method of claim 1 , wherein the culture system further comprises nicotinamide.

6. A method for maintaining human pluripotent stem cells in an undifferentiated state, comprising:

providing human umbilical cord fibroblast feeder cells comprising

expanding human umbilical cord cells to obtain human umbilical cord feeder cells, and

isolating human umbilical cord fibroblast feeder cells from the human umbilical cord feeder cells, to obtain human umbilical cord fibroblast feeder cells; and

incubating the human pluripotent stem cells in a culture system comprising the human umbilical cord fibroblast feeder cells, and the culture system is free from antibacterial agents and mercaptoethanol.

7. The method of claim 6 , wherein the human umbilical cord feeder cells consists essentially of the human umbilical cord fibroblast feeder cells.

8. The method of claim 7 , wherein the human umbilical cord feeder cells consist of the human umbilical cord fibroblast feeder cells.

9. The method of claim 6 , wherein the culture system further comprises nicotinamide.

Continuity (3)
Division 11794262
Provisional Application 60639809 · Dec 29, 2004
Related Publication 20110177594A1 · Jul 21, 2011